The outcomes affirm conclusions drawn by Bagli et al. [1], who executed a examine that included ten patients diagnosed with CRAO who received HBOT. As well as acquiring 20 sessions of HBOT, oral acetazolamide and topical beta-blockers were administered to your patients in the earliest doable time.